+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy

  • ID: 2559797
  • Report
  • Region: Italy
  • 138 Pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3
Italy’s Pharmaceutical Industry Value Will Drop to $18.6 Billion by 2020 due to Struggling Economy
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy

Summary

The industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Italy. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Italy. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by a team of industry experts.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Italy, and includes -
  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Pfizer, Recordati, Menarini, Chiesi and Zambon) and profiles and SWOT analyses of the major players in the medical device market (Abbott, Medtronic, GE Healthcare, Roche and Esaote)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Italy
  • Porter’s five forces analysis for pharmaceutical and medical devices market of Italy
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities and challenges to growth in the Italian healthcare market.
Reasons to buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving the Italian healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the Italian healthcare market.
Note: Product cover images may vary from those shown
2 of 3
  • Executive Summary
  • Overview of Pharmaceutical Market
  • Overview of Medical Device Market
  • Deals Analysis
  • Porter’s Five Forces Model
  • Market Access
  • Country Healthcare Landscape
  • Opportunities and Challenges
  • Appendix

List of Tables
Table 1: Discounts Charged to Pharmacies, Italy, 2019
Table 2: Top Five Therapeutic Areas by Incidence Rate (per 1000 person), Italy, 2017
Table 3: Medical Device Market, Italy, Revenue by Segment ($B)
Table 4: IVD Market, Italy, Revenue ($M) and Market Share (%) of Major Companies
Table 5: Cardiovascular Devices, Italy, Revenue ($M) and Market Share (%) of Major Companies
Table 6: Nephrology and Urology Device Market, Italy, Revenue ($M) and Market Share (%) of Major Companies
Table 7: Orthopedic Devices Market, Italy, Revenue ($M) and Market Share (%) of Major Companies
Table 8: Hospital Supplies Market, Italy, Revenue ($M) and Market Share (%) of Major Companies
Table 9: Reimbursement Categorization, Italy, 2016
Table 10: Managed Entry Agreements, Italy, 2016
Table 11: Types of Private Insurance Providers, Italy, 2019
Table 12: Patent Fees, Italy, 2019
Table 13: Trademark Fees, Italy, 2019
Table 14: Label of a Pharmaceutical Product, Italy, 2017
Table 15: Minimum Particulars to Appear on Blisters or Strips
Table 16: Minimum Particulars to Appear on Small Primary Packaging

List of Figures
Figure 1: Pharmaceutical Market, Italy, Revenue ($B), 2010-2017
Figure 2: Medical Device Market, Italy, Revenue ($B), 2015-2020
Figure 3: Number of Deals (2018-2019)
Figure 4: 2018-19 Deal Overview By Region
Figure 5: Country Profile, Italy, 2018
Figure 6: Pharmaceutical Market, Italy, Revenue ($B), 2010-2017
Figure 7: Pharmaceutical Market, Italy, Revenue Forecast ($B), 2018-2022
Figure 8: Pharmaceutical Market, Italy, Pharmaceutical Exports
Figure 9: Pharmaceutical Market, Italy, Top Export Partners
Figure 10: Pharmaceutical Market, Italy, Pharmaceutical Imports
Figure 11: Pharmaceutical Market, Italy, Top Import Partners
Figure 12: Consumptions of In-patent and Off-patent Medicines, Italy, 2017
Figure 13: Consumption of Generics DDD/1,000, Italy, 2017
Figure 14: Funded Innovative Drugs, Italy, 2017
Figure 15: Biotechnology Groups, Italy, 2018
Figure 16: Biosimilars, Italy, 2018
Figure 17: Pharmaceutical OTC Market, Italy, Revenue ($B), 2010-2017
Figure 18: Major OTC Drug Classes (Share%), Italy, 2017
Figure 19: Pharmaceutical Market, Supply Chain, Italy, 2017
Figure 20: Top Five Therapeutic Areas by Incidence Rate (per 1000 person), Italy, 2017
Figure 21: Pharmaceutical Market, Major Players, Italy
Figure 22: Medical Device Market, Italy, Revenue ($B), 2015-2020
Figure 23: Medical Device Market, Italy, Revenue Forecast ($B), 2021-2025
Figure 24: Medical Device Market, Italy, Revenue by Segment ($B), 2018
Figure 25: IVD Market, Italy, Revenue ($B), 2015-2022
Figure 26: IVD Market, Italy, Market Share of Major Players (%)
Figure 27: Cardiovascular Devices Market, Italy, Revenue ($B), 2015-2022
Figure 28: Cardiovascular Devices Market, Italy, Market Share of Major Players (%)
Figure 29: Nephrology and Urology Device Market, Italy, Revenue ($B), 2015-2022
Figure 30: Nephrology and Urology Device Market, Italy, Market Share of Major Players (%)
Figure 31: Orthopedic Market, Italy, Revenue ($B), 2015-2022
Figure 32: Orthopedic Devices Market, Italy, Market Share of Major Players (%)
Figure 33: Hospital Supplies Market, Italy, Revenue ($B), 2015-2022
Figure 34: Hospital Supplies Market, Italy, Market Share of Major Players (%)
Figure 35: Diagnostic Market, Italy, Revenue ($B), 2015-2020
Figure 36: Diagnostic Market, Italy, Revenue ($B), 2021-2025
Figure 37: Medical Device Market - Major Players
Figure 38: Deal Value and Deal Count, Pharmaceutical Market, Italy, 2018-2019
Figure 39: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Italy, 2018-2019
Figure 40: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Italy, 2018-2019
Figure 41: Top Five Therapy Areas by Deal Value, Pharmaceutical Market, Italy, 2018-2019
Figure 42: Top Five Therapy Areas by Deal Number, Pharmaceutical Market, Italy, 2018-2019
Figure 43: M&A Deals by Therapy Area, Pharmaceutical Market, Italy, 2018-2019(by value and by number)
Figure 44: Venture Financing Deals by Therapy Area, Pharmaceutical Market Italy, 2018-2019(by value and by number)
Figure 45: Medical Device Market Deals, Italy, 2018-2019(by deal value, $M)
Figure 46: Medical Device Market Deals, Italy, 2018 -2019(by deal count)
Figure 47: Medical Device Market Deals Share (by deal count), Italy, 2018 - 2019
Figure 48: Medical Device Market Deals Share (by deal value), Italy, 2018 - 2019
Figure 49: Top Five Therapy Areas by Deal Value, Medical Device, Italy, 2018-2019
Figure 50: Top Five Therapy Areas by Deal Number, Medical Device, Italy, 2018-2019
Figure 51: M&A Deals by Therapy Area, Medical Device, Italy, 2018-2019 (by number)
Figure 52: Venture Financing Deals by Therapy Area, Medical Device, Italy, 2018-2019(by value and by number)
Figure 53: Private Equity Deals by Therapy Area, Medical Device Italy, 2018-2019(By number)
Figure 54: Organizational Structure of Ministry of Health, Italy, 2019
Figure 55: Overview of Healthcare System, Italy, 2014
Figure 56: Reimbursement of Medicinal Products, Italy, 2016
Figure 57: Reimbursement Options, Italy, 2016
Figure 58: Reimbursement of Medical Devices in Hospital Setting, Italy
Figure 59: Reimbursement of Medical Devices in Ambulatory Setting, Italy
Figure 60: OOP Expenditure (% of total expenditure on health), Italy, 2010-2017
Figure 61: Annual Rate of Change (%), Health Price Index, Italy, 2010-2017
Figure 62: Mechanisms to Monitor Pharmaceutical Pricing, Italy, 2019
Figure 63: AIFA, Organizational Structure, Italy, 2019
Figure 64: National Procedure, Italy, 2019

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Italy’s Pharmaceutical Industry Value Will Drop to $18.6 Billion by 2020 due to Struggling Economy.

The pharmaceutical industry in Italy is set to decline from $21.3 billion in 2016 to $18.6 billion by 2020, at a negative compound annual growth rate of 3.3%, primarily due to the country’s struggling economy.

The company’s latest report* states that the strict pricing of drugs through negotiations and external and internal reference pricing is a barrier to the launch of innovative molecules, and that sales of generics and over-the-counter drugs will increase over the forecast period.

Adam Dion, MSc, Senior Industry Analyst, explains: “The pharmaceutical industry in Italy will face a number of challenges over the next few years. An increase in the Italian government’s debt relative to GDP, and the country’s poor growth record, will decrease cash flow in the country, meaning the industry will stagnate."

The Italian economy is also vulnerable to fluctuations in the demand and supply of goods and services in other countries. The Eurozone crisis is likely to result in lower demand for Italian products from other European countries, reducing exports and engendering a hostile environment for innovation or investment. India and China also present a threat as they have an edge in the generics market, and may usurp sales away from Italy’s domestic pharmaceutical space.

Dion concludes: “Despite the tough economic environment faced by those operating within the Italian pharmaceutical industry, the report believes there will be a number of opportunities to counteract declining sales, including efficient patent policies, E-Health programs, and government reforms to reduce public debt. Indeed, more companies will be interested in research and development after the Italian Patent and Trademark Office has created efficient patent policies to protect them.”

*CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy

This report provides analysis of the pharmaceutical market in Italy, and the impact of the current and emerging market access strategies used by the pharmaceutical industry for new and existing drugs. It includes annualized market data from 2015 and forecast to 2020, and discusses the regulatory requirements, key health insurance trends, recent government healthcare reforms, and general industry trends.

This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by a team of industry experts.
Note: Product cover images may vary from those shown
Adroll
adroll